Skip Navigation Links

Bookmark and Share
Azura Ophthalmics raises $28m for registration studies for treatment of leading cause of dry eye disease
-- Medical Research Commercialisation Fund (MRCF) in raise for registration study to treat Meibomian gland dysfunction, the leading cause of Dry Eye Disease -- Meibomian gland dysfunction affects more than 30 ...

Full "IntellAsia: Resources" article

Disclaimer | Terms Of Use And Privacy Statement

© Metals News. All rights reserved.